Danuta Szczesna-Cordary | Molecular Biology | Best Researcher Award-1633

Prof. Dr. Danuta Szczesna-Cordary | Molecular Biology | Best Researcher Award

University of Miami, United States

๐Ÿ‘จโ€๐ŸŽ“Profiles

๐Ÿ“š Early Academic Pursuits

Dr. Danuta Szczesna-Cordary began her academic journey at the University of Warsaw, where she earned a Masterโ€™s degree in Physical Chemistry in 1976. She continued her scientific exploration at the Polish Academy of Sciences, earning her Ph.D. in Natural Sciences from The Nencki Institute of Experimental Biology in 1989. These formative years laid a robust foundation for her career in molecular and cellular pharmacology.

๐Ÿข Professional Endeavors

She holds the esteemed position of Professor with Tenure in the Department of Molecular & Cellular Pharmacology at the University of Miami. She also has a secondary appointment at the Sylvester Comprehensive Cancer Center, contributing to interdisciplinary advancements in medical research. Early in her career, she completed a prestigious American Heart Association Postdoctoral Fellowship in Massachusetts, focusing on fluorescence microscopy of thin filament proteins in myofibrils.

๐Ÿงช Contributions and Research Focus

Her research focuses on the molecular mechanisms of cardiac myopathies and the development of therapeutic approaches for conditions such as hypertrophic cardiomyopathy (HCM). Her groundbreaking work includes: Investigating myosin light chain phosphorylation as a potential target for cardiac repair. Authoring high-impact articles such as "Novel cardiac myosin inhibitor for hypertrophic cardiomyopathy" published in Journal of General Physiology (2024). Contributing editorially to significant works like "Physiology of Human Myopathies" in Frontiers in Physiology (2023).ย Her research holds immense promise for advancing precision medicine in cardiology.

๐ŸŒ Impact and Influence

Her contributions to science resonate globally, particularly in the realms of cardiomyopathy and muscle physiology. Her work has earned citations in leading journals and inspired collaborative efforts across the Biophysical Society, American Heart Association (AHA), and the European Society of Cardiology (ESC). Through these platforms, she has shaped discussions and policies on cardiovascular health.

๐Ÿ”ฌ Technical Skills

A scientist of multifaceted expertise, She possesses advanced skills in: Fluorescence Microscopy for thin filament protein analysis. Molecular and Cellular Pharmacology techniques. Investigating the biophysical properties of striated muscle systems.ย Her technical acumen has facilitated novel discoveries in cardiac physiology and therapeutic intervention.

๐Ÿ‘ฉโ€๐Ÿซ Teaching Experience

As a dedicated educator, She has mentored numerous graduate and postdoctoral fellows. Her mentorship emphasizes critical thinking, fostering innovation in young researchers tackling complex challenges in molecular pharmacology.

๐ŸŒŸ Legacy and Future Contributions

Her legacy is deeply rooted in her pursuit of excellence in cardiovascular research. Looking ahead, she aims to: Advance cardiac therapeutics by targeting molecular pathways of myopathies. Collaborate with global institutions to improve precision medicine strategies. Mentor the next generation of scientists to address emerging health challenges.

๐Ÿ“–Notable Publications

 

Duk-Hwa Kwon | Molecular Biology | Best Researcher Award -1610

Dr. Duk-Hwa Kwon | Molecular Biology | Best Researcher Award

Chonnam National University Medical School, South Korea

๐Ÿ‘จโ€๐ŸŽ“Profiles

๐ŸŽ“ Early Academic Pursuits

He began his academic journey in biotechnology, earning his B.S. degree from Chonnam National University, Gwangju, Korea, between 2002 and 2007. Building on his passion for the life sciences, he pursued an M.S. in Biotechnology at the same institution from 2007 to 2009. His early academic endeavors laid a strong foundation in the principles of biological sciences, molecular mechanisms, and biotechnological applications.

๐Ÿ›๏ธ Professional Endeavors

Following his academic training, He advanced to a Ph.D. in Biomedical Sciences (2011โ€“2014) at Chonnam National University's Medical School. Post-graduation, he transitioned to a postdoctoral fellowship in the Department of Pharmacology at the same university, where he has been serving since 2014. In this role, Dr. Kwon has collaborated on cutting-edge pharmacological research, contributing significantly to the university's academic and scientific reputation.

๐Ÿ”ฌ Contributions and Research Focus

His research has primarily focused on the intersection of biotechnology and pharmacology. His work has explored molecular mechanisms underlying diseases, drug discovery, and the development of innovative therapeutic strategies. He has contributed to understanding biomedical pathways, significantly advancing pharmacological knowledge and biomedical applications.

๐ŸŒ Impact and Influence

His academic and professional contributions have had a profound impact on the fields of biotechnology and pharmacology. By combining foundational biotechnology knowledge with clinical applications, he has addressed critical health challenges, providing innovative solutions to modern medical problems. His work continues to influence the direction of pharmacological research globally.

๐Ÿ“š Academic Citations

As a researcher, He has accumulated a noteworthy number of citations, reflecting the academic community's recognition of his impactful research. His publications have appeared in prestigious journals, marking him as a key contributor to his field.

๐Ÿ› ๏ธ Technical Skills

He possesses advanced technical skills in biotechnology and pharmacology, including molecular biology techniques, drug screening methods, and cell culture systems. His expertise also spans advanced pharmacological modeling and data analysis.

๐Ÿง‘โ€๐Ÿซ Teaching Experience

In addition to his research roles, He has contributed to academic teaching. His mentorship of students and involvement in laboratory training have helped shape the next generation of researchers and scientists in biotechnology and pharmacology.

๐ŸŒŸ Legacy and Future Contributions

His dedication to biomedical sciences and pharmacology positions him as a leading figure in his field. His legacy lies in his ability to bridge the gap between biotechnology and clinical applications, ensuring that his contributions continue to benefit academia and industry. Looking forward, Dr. Kwon is poised to expand his research into innovative therapies, furthering advancements in healthcare and biomedical science.

๐Ÿ“–Notable Publications

MDM2 E3 ligase-mediated ubiquitination and degradation of HDAC1 in vascular calcification

Authors: DH Kwon, GH Eom, JH Ko, S Shin, H Joung, N Choe, YS Nam, HK Min, ...
Journal: Nature Communications
Year: 2016

The microRNA miRโ€124 inhibits vascular smooth muscle cell proliferation by targeting S100 calciumโ€binding protein A4 (S100A4)

Authors: N Choe, DH Kwon, S Shin, YS Kim, YK Kim, J Kim, Y Ahn, GH Eom, ...
Journal: FEBS Letters
Year: 2017

Estrogen-related receptor gamma induces cardiac hypertrophy by activating GATA4

Authors: DH Kwon, GH Eom, HJ Kee, YS Nam, YK Cho, DK Kim, JY Koo, HS Kim, ...
Journal: Journal of Molecular and Cellular Cardiology
Year: 2013

Characterization of circular RNAs in vascular smooth muscle cells with vascular calcification

Authors: J Ryu, DH Kwon, N Choe, S Shin, G Jeong, YH Lim, J Kim, WJ Park, ...
Journal: Molecular Therapy-Nucleic Acids
Year: 2020

PP2A negatively regulates the hypertrophic response by dephosphorylating HDAC2 S394 in the heart

Authors: S Yoon, T Kook, HK Min, DH Kwon, YK Cho, M Kim, S Shin, H Joung, ...
Journal: Experimental & Molecular Medicine
Year: 2018

Long noncoding RNAs in vascular smooth muscle cells regulate vascular calcification
Authors: G Jeong, DH Kwon, S Shin, N Choe, J Ryu, YH Lim, J Kim, WJ Park, ...
Journal: Scientific Reports
Year: 2019